Search Results for "Optivar"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Optivar. Results 1 to 3 of 3 total matches.
See also: azelastine

Epinastine Ophthalmic Solution (Elestat)

   
The Medical Letter on Drugs and Therapeutics • Apr 26, 2004  (Issue 1181)
Azelastine hydrochloride 0.05% 1 drop bid Optivar (MedPointe) $27.75 Epinastine hydrochloride 0.05% 1 drop ...
Epinastine HCl, an H1-receptor antagonist and mast cell stabilizer, has been approved by the FDA for use in a 0.05% ophthalmic solution (Elestat - Allergan/Inspire) for prevention of itching associated with allergic conjunctivitis. The drug is available orally in Europe and Asia.
Med Lett Drugs Ther. 2004 Apr 26;46(1181):35-6 |  Show IntroductionHide Introduction

Alcaftadine (Lastacaft) for Allergic Conjunctivitis

   
The Medical Letter on Drugs and Therapeutics • Mar 07, 2011  (Issue 1359)
103.49 Optivar(Meda) C 132.29 (0.05% soln*) (6 mL) Bepotastine Bepreve (Ista) 1 drop bid C 105.00 ...
Alcaftadine (Lastacaft – Allergan), an ophthalmic H1-antihistamine, has been approved by the FDA for prevention of itching associated with allergic conjunctivitis in patients > 2 years old.
Med Lett Drugs Ther. 2011 Mar 7;53(1359):19-20 |  Show IntroductionHide Introduction

Bepotastine (Bepreve) - An Ophthalmic H1-Antihistamine

   
The Medical Letter on Drugs and Therapeutics • Feb 08, 2010  (Issue 1331)
and Mast-Cell Stabilizers Azelastine – generic 1 drop bid 104.07 (6 mL) Optivar (Meda) 115.63 (0.05 ...
Bepotastine besilate 1.5% ophthalmic solution (Bepreve - ISTA Pharmaceuticals), an H1-antihistamine, has been approved by the FDA for topical treatment of itching associated with allergic conjunctivitis in patients ≥2 years old. Bepotastine was first developed in an oral systemic formulation and has been used as such for treatment of allergic rhinitis in Japan.
Med Lett Drugs Ther. 2010 Feb 8;52(1331):11-2 |  Show IntroductionHide Introduction